First‐in‐Human Studies for a Selective RET Tyrosine Kinase Inhibitor, GSK3179106, to Investigate the Safety, Tolerability, and Pharmacokinetics in Healthy Volunteers
暂无分享,去创建一个
A. Verticelli | K. Hacquoil | S. Shakib | P. Gorycki | Beth Ann Reedy | Kristen E Pannullo | R. O’Connor-Semmes | Melisa Cooper